September 7, 2016
By Samantha Smith In the wake of drug manufacturer Mylans’ price spike of their EpiPen epinephrine auto injector devices by 400 percent, concerns now lie in how area residents can cover the exorbitant cost. In a CNBC article last month, Heather Bresch, CEO of Mylan, attributed the rise in the compa...